ClinConnect ClinConnect Logo
Search / Trial NCT05994014

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]

Launched by JOHNS HOPKINS UNIVERSITY · Aug 8, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Coronary Imaging Prevention Early Detection

ClinConnect Summary

This clinical trial is comparing two types of imaging tests—PET/CT and cardiac CT—to see which one better detects coronary atherosclerotic disease, a condition where plaque builds up in the arteries of the heart. Early detection is important because it helps doctors take steps to prevent serious heart problems. The study will involve 33 patients who are experiencing symptoms that suggest they might have coronary artery disease (CAD) and have been referred for cardiac CT testing.

To participate in this study, you need to be at least 18 years old and have stable symptoms that make your doctor suspect you might have coronary heart disease. However, if you have a history of heart disease, are pregnant, have certain heart conditions like atrial fibrillation, are significantly overweight, or have other serious health issues, you would not be eligible. Participants will undergo imaging tests and will help researchers understand which method is more effective for detecting heart disease, which could lead to better care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female patients
  • 18 years or older
  • referred for coronary CT angiography because of suspected coronary heart disease (CHD) with stable symptoms
  • Exclusion Criteria:
  • The patient has a history of coronary heart disease, defined by prior myocardial infarction or prior coronary artery revascularization.
  • Pregnancy.
  • Atrial fibrillation.
  • Morbid obesity defines as a body mass index of \>40.
  • The patient has any other clinically significant medical condition that in the opinion of the Investigator could impact the patient's ability to successfully complete the trial.

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Armin Zadeh, MD PhD MPH

Principal Investigator

Johns Hopkins School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported